Year All202620252024202320222021202020192018201720152014 May 28, 2026 CG Oncology to Present at Upcoming Investor Conferences in June May 19, 2026 SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award May 15, 2026 CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients May 11, 2026 CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC May 08, 2026 CG Oncology Reports First Quarter 2026 Financial Results and Provides Business Updates May 05, 2026 CG Oncology to Present at Upcoming Investor Conferences in May Feb 27, 2026 CG Oncology Reports 2025 Year End Financial Results and Provides Business Updates Feb 23, 2026 CG Oncology to Present at the TD Cowen 46th Annual Health Care Conference Jan 09, 2026 CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC Jan 06, 2026 CG Oncology to Present at the 44th Annual J.P. Morgan Healthcare Conference
May 19, 2026 SUO-CTC and CG Oncology Announce Award Recipients of the Second Annual Non-Muscle Invasive Bladder Cancer (NMIBC) Research Fellowship Award
May 15, 2026 CG Oncology Reports Positive First Results from CORE‑008 Cohort CX Phase 2 Trial Evaluating Intravesical Combination Therapy in High-Risk BCG-Exposed and BCG-Unresponsive Patients
May 11, 2026 CG Oncology’s Presence at American Urological Association (AUA) Annual Meeting Underscores its Strong Commitment to NMIBC
Jan 09, 2026 CG Oncology Provides Updated Timeline for PIVOT-006 Phase 3 Topline Data in Intermediate-Risk NMIBC